U.S. biotech industry research and development expenses by region 2012-2014

This statistic shows the research and development expenses of the U.S. biotech industry - represented by public biotech companies only from 2012 to 2014, sorted by (metropolitan) region. In New England, the R&D expense incurred by such companies came to some 5.3 billion U.S. dollars in 2013.

U.S. biotech industry research and development expenses from 2012 to 2014, by geographic area (in million U.S. dollars)*

201220132014
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $59 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Sources

Release date

2015

Region

United States

Survey time period

2012 to 2014

Supplementary notes

* Expenses of public biotech companies only. Figures for 2012-2013 were taken from previous editions of the same report.

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Biotechnology in Germany"

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.